Elonia Martin, CRC

Northstar Medical CenterChicago, Illinois - 60657 (773-296-2400) |
- CLINICAL TRIALS 1
- CONDITIONS0
- INTERVENTIONS1
- SINCE2008

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
August 2008 - October 2010
Ibalizumab



